0001453687-22-000025.txt : 20220105
0001453687-22-000025.hdr.sgml : 20220105
20220105163630
ACCESSION NUMBER: 0001453687-22-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRABER PETER G
CENTRAL INDEX KEY: 0001284500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 22511686
MAIL ADDRESS:
STREET 1: 430 THAMER LANE
CITY: HOUSTON
STATE: TX
ZIP: 77025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wf-form4_164141856949283.xml
FORM 4
X0306
4
2022-01-03
0
0001453687
SELECTA BIOSCIENCES INC
SELB
0001284500
TRABER PETER G
C/O SELECTA BIOSCIENCES, INC.
65 GROVE STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Medical Officer
Common Stock
2022-01-03
4
A
0
90200
0
A
254581
D
Employee Stock Option (right to buy)
3.31
2022-01-03
4
A
0
415900
0
A
2032-01-02
Common Stock
415900.0
415900
D
Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026.
This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
2022-01-05